Navigation Links
ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2011
Date:1/26/2012

SAN DIEGO, Jan. 26, 2012 /PRNewswire/ --ResMed Inc. (NYSE: RMD) today announced record revenue and income for the quarter ended December 31, 2011.  Revenue for the quarter ended December 31, 2011 was $332.7 million, a 9% increase (also a 9% increase on a constant currency basis) over the quarter ended December 31, 2010.  For the quarter ended December 31, 2011, net income was $62.9 million, an increase of 8%, compared to the quarter ended December 31, 2010.  Diluted earnings per share for the quarter ended December 31, 2011 were $0.42, an increase of 14% compared to the quarter ended December 31, 2010.  

(Logo:  http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

SG&A expenses were $100.6 million for the quarter ended December 31, 2011, an increase of $9.0 million, or 10% (a 9% increase on a constant currency basis) over the quarter ended December 31, 2010.  The increase in SG&A was primarily due to expenses necessary to support sales growth.  SG&A costs were 30% of revenue in the quarter ended December 31, 2011, compared to 30% in the quarter ended December 31, 2010.R&D expenses were $27.2 million for the quarter ended December 31, 2011, or 8% of revenue.  R&D expenses increased by 24% (a 21% increase on a constant currency basis) compared to the quarter ended December 31, 2010.  

The company amortized acquired intangibles of $3.7 million ($2.7 million, net of tax) during the quarter ended December 31, 2011.  Stock-based compensation costs incurred during the quarter ended December 31, 2011 of $7.4 million ($5.8 million, net of tax) consisted of expenses associated with stock options, restricted stock units, and our employee stock purchase plan.  

For the six months ended December 31, 2011, revenue was $647.5 m
'/>"/>

SOURCE ResMed Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ResMed Announces Change to Outside US Dial-in Number for Conference Call and Webcast to Discuss Second Quarter 2012 Results
2. ResMed Announces Conference Call and Webcast to Discuss Second Quarter 2012 Results
3. ResMed Inc. Announces Financial Results for the Quarter Ended September 30, 2011
4. ResMed Announces Conference Call and Webcast to Discuss First Quarter 2012 Results
5. ResMed Inc. to Present at Upcoming Conferences
6. CareFusion and ResMed Announce Distribution Agreement for U.S. Hospital Market
7. ResMed Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year End 2011 Results
8. ResMed Announces Acquisition of BiancaMed
9. ResMed Announces New iPhone App
10. ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011
11. The Next Generation in Bilevel Therapy Now Available on ResMeds Award-Winning S9™ Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... The Coalition of State Rheumatology Organizations ... professional rheumatology societies, today released the findings of ... of biosimilars and the potential impact of these ... are medicines that are highly similar, but not ... from generic medications in that it is impossible ...
(Date:7/1/2015)... 2015 Research ... addition of the "2015 New Frontiers ... Business Challenges, Emerging Technologies, Competitive Landscape" ... New Frontiers in European Clinical Chemistry and ... Landscape is a new five-country strategic analysis ...
(Date:7/1/2015)... , June 24, 2015 ... announced the addition of the "2015 Strategies ... their offering. This new 175-page report ... segments, including diabetes (strips and meters), pregnancy, ovulation, ... size, growth, regulatory requirements, technologies, and competitive profiles. ...
Breaking Medicine Technology:Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 22015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape 22015 Strategies in the Home/Self Testing Market 2
... p.m. Eastern Time - SOUTH SAN FRANCISCO, Calif., May ... ), a biopharmaceutical company focused on oncology, today reported ... 2009, and provided a corporate update. "The completion of ... picoplatin for the second-line treatment of small cell lung ...
... Burden of RSV Disease Presented at Pediatric Academic ... announced results from a recent study it sponsored, ... in Oakland, CA, assessing risk factors for respiratory ... infants born at 33 weeks gestational age [GA] ...
Cached Medicine Technology:Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 2Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 3Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 4Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 5Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 6Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 7Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 8Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update 9MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants 2MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants 3
(Date:7/2/2015)... ... July 02, 2015 , ... It’s no secret that what we consume can have an effect on the body. ... easily feel dehydrated or perhaps even undernourished if not eating enough of the right foods, as ... an easy time of year to overdo it on the food front as well, with sweet ...
(Date:7/2/2015)... ... 2015 , ... Cs &A, the leader in Semi Timing ... and publication of their newest offering to complement the existing line of Market ... Designed in support of coverage for the full spectrum of Semi Timing solutions ...
(Date:7/1/2015)... ... July 01, 2015 , ... In the United States, summer ... many Middle-Eastern countries like Saudi Arabia and Dubai, the summer temperatures are so hot, ... climates. Celebrity dentist Dr. Sam Saleh of ORA Dentistry Spa notes that a trip ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... the manufacturers of Levaquin ( http://www.injurybeacon.com/levaquin/lawsuit/ ) has granted the Defendants’ Motion for ... District of West Virginia on June 26th, the Court rejected the Plaintiff’s ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... retail, long term care, specialty, combo, and compounding pharmacy operations, announces the most ... to the Cardinal Health RBC event at the Venetian Las Vegas, ...
Breaking Medicine News(10 mins):Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4
... (MEMPHIS, Tenn. December 10, 2011) Symptoms improved significantly ... a single treatment with gene therapy developed by researchers ... demonstrated to be safe in a clinical trial conducted ... The findings of the six-person study mark the ...
... , FRIDAY, Dec. 9 (HealthDay News) -- ... days after giving birth have an increased risk of ... Researchers examined data from more than 120,000 Danish women ... psychiatric care either as an outpatient or an inpatient ...
... 9 (HealthDay News) -- Many American soldiers who suffer burns ... or rapid decline in kidney function that is potentially deadly. ... acute kidney injury among 692 U.S. military casualties who were ... two different classification systems, the researchers found that rates of ...
... new partnership between the Centre for Reviews and Dissemination ... is launched today., PubMed Health is a new online ... (NCBI) at the US National Library of Medicine (NLM) ... summaries and full text of selected systematic reviews and ...
... BOSTON Cancer of the liver rare in the ... can result from environmental exposures or infections like chronic ... at Dana-Farber Cancer Institute have identified a mechanism in mice ... into cancerous ones. In addition, they demonstrated in a ...
... Premature infants have fewer types of bacteria in their stomachs ... However, the bacteria and other microbes often found in preemies, ... Duke University Medical Center noted. "You see diversity emerge ... to be stuck -- they have fewer types of bacteria ...
Cached Medicine News:Health News:Gene therapy achieves early success against hereditary bleeding disorder 2Health News:Gene therapy achieves early success against hereditary bleeding disorder 3Health News:Psych Episode Near Childbirth May Presage Bipolar Disorder 2Health News:Burn-Casualty Soldiers at High Risk for Kidney Injury, Study Finds 2Health News:Researchers identify a novel therapeutic approach for liver cancer 2Health News:Preemies Infected With More Dangerous Types of Bacteria: Study 2
... Collar and Stabilizer Plastazote® with ... Hook-and-pile closure straps. Chin cradle ... pieces may be interchanged for ... to the standard Philadelphia Collar ...
Urethrotome - non-optical...
Optical Urethrotome for Telescope 2.7 mm for children....
... The USA Elite ... Visual Urethrotomes are utilized ... strictures and bladder neck ... The visual obturator converts ...
Medicine Products: